The majority of cancers detected in PPM1D-transgenic mice were similar to those reported in irradiated p53-mutant mice post-irradiation [32,33,34], indicating a similar tumor phenotype caused by p53 impairment rather than p53 absence. Here, PPM1D is linked to neoplasm.